2017/2532(DEA)
OTC derivatives, central counterparties and trade repositories: risk-mitigation techniques for OTC derivative contracts not cleared by a central counterparty; correcting Delegated Regulation (EU) 2016/2251
Basic information
2017/2532(DEA)
DEA - Delegated acts procedure
Supplementing 2010/0250(COD)
Subject
2.50.03 Securities and financial markets, stock exchange, CIUTS, investments
2.50.08 Financial services, financial reporting and auditing
Status
Procedure completed - delegated act enters into force
Key players
-
European Parliament
Committee responsible Rapporteur Appointed ECONEconomic and Monetary Affairs
Key events
| Date | Event | Reference | Summary |
|---|---|---|---|
| 20/01/2017 | Non-legislative basic document published | C(2017)00149 | |
| 20/01/2017 | Initial period for examining delegated act 1.0 month(s) | ||
| 01/02/2017 | Committee referral announced in Parliament | ||
| 17/02/2017 | Delegated act not objected by Council | ||
| 28/02/2017 | Delegated act not objected by Parliament |
Technical information
| Procedure | Information |
|---|---|
| Procedure reference | 2017/2532(DEA) |
| Procedure type | DEA - Delegated acts procedure |
| Nature of procedure | Examination of delegated act |
| Supplementing 2010/0250(COD) | |
| Stage reached in procedure | Procedure completed - delegated act enters into force |
| Committee dossier |
ECON/8/09098
|
Documentation gateway
-
Document type Reference Date Summary Non-legislative basic document C(2017)00149 20/01/2017